Top Markets
Coin of the day
Mercury Biopharmaceutical Corporation Mercury Biopharmaceutical Corporation

Mercury Biopharmaceutical Corporation

6932
Clasificación en acciones #23452
Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury... Founded in 2019 and headquartered in New Taipei City, Taiwan, Mercury Biopharmaceutical Corporation is dedicated to creating innovative pharmaceutical solutions for medical conditions currently lacking adequate treatment options. A cornerstone of their strategy is the proprietary StackDose platform, an advanced drug development system designed to formulate novel medication delivery methods. This platform facilitates precisely timed drug release, targeted absorption at specific locations within the body, and flexible dosage modifications. The primary objective of StackDose is to significantly boost the bioavailability of active pharmaceutical ingredients, leading to a reduction in required drug dosages and fewer adverse effects. Their development pipeline currently addresses a variety of ailments, such as erectile dysfunction, pulmonary hypertension, sleep disturbances, benign prostatic hyperplasia, angina, migraines, hypertension, and pain management.
Precio por acción
$0.17616661
Última sincronización: 2026-08-21
Capitalización bursátil
$73.48M
Cambio (1 día)
0.18%
Cambio (1 año)
-37.76%
País
TW
Comercio Mercury Biopharmaceutical Corporation (6932)

Categoría

Historial del precio de la acción de Mercury Biopharmaceutical Corporation (6932)
Precio más alto de cierre: $0.19 el 2026-08-01

Precio más bajo de cierre: $0.35 el 2022-12-01
Historial del precio de la acción de Mercury Biopharmaceutical Corporation desde 2022 hasta 2026
Desempeño anual del precio de la acción
Año Rendimiento
2026 (TTM) -18.88%
2025 -28.11%
2024 -33.04%
2023 75.06%
2022 0.00%
Precio de la acción de empresas similares o competidoras
Empresa Precio de la acción Cambio 1a% País
$171.67 -
DE
$163.63 24.47%
DE
$37.61 20.44%
JP
$223.11 32.20%
CH
$20.99 11.67%
IN